Trial intelligence / Profile preview

Anesthetics and Postoperative Cognitive Dysfunction in Endovascular Surgery

NCT02107170Phase 4Completed

Start
Feb 2014
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of sevoflurane in aortic aneurysm and arteriosclerosis obliterans (2 arms). Primary endpoint: Number of patients with postoperative cognitive dysfunction at 7 days. Started Feb 2014; status: completed.

02

Drugs

sevoflurane
03

Conditions

aortic aneurysmarteriosclerosis obliterans

Beyond the preview

Go deeper on NCT02107170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02107170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call